Lucia Peixoto

Has grant

Associate Professor

Washington State University - Spokane
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Lucia Peixoto is an Associate Professor at Washington State University Spokane, USA. Her research focuses on the interactions between sleep, brain development, and Autism Spectrum Disorders, emphasizing the molecular dynamics and critical periods associated with these phenomena. Recent articles authored by Dr. Peixoto explore topics such as the impact of MeCP2 loss on sleep deficits and the role of Shank3 in sleep development.

Recent Grants

Grant: Open

The role of sleep on chromatin and transcriptional regulation across vertebrate evolution.

Open Date: 2022-09-20

Close Date: 2027-08-31

Grant: Close

Understanding the interaction between sleep and SHANK3/B-catenin signaling in Autism

Open Date: 2022-08-01

Close Date: 2023-07-31

Grant: Close

Shank3 in Autism and sleep disturbances

Open Date: 2017-09-30

Close Date: 2021-08-31

Grant: Close

Understanding insomnia in the Autism Spectrum using mouse models

Open Date:

Close Date:

Articles (11)

Year:

2025

This study investigates different time points of sleep deprivation and recovery sleep to better understand the molecular processes influenced by sleep and lack of sleep. This study highlights redox metabolism, chromatin regulation, and DNA damage/repair as molecular mechanisms linked to sleep homeostasis while showing the effects of stress are probably non-sleep-specific based on transcriptional dynamics.

Year:

2025

Year:

2025

Introduction Sleep problems occur at a higher rate in autism spectrum disorder (ASD) than in typical development (TD). Polysomnography (PSG) is the gold-standard for collecting objective sleep data, but it is labor-intensive, intrusive, requires patients to stay overnight in an unfamiliar environment, and typically limited to one night of recording decreasing its validity and scalability to larger cohorts of ASD individuals. We tested a non-contact biomotion sensor, the SleepScore Max (SSM) to determine the acceptability of longitudinal use and feasibility of estimating sleep characteristics in ASD and TD youth in the home. Methods 7 ASD (M=13.0y, SD=2.2y, with community ASD diagnosis) and 6 TD (M=13.3y, SD=2.3 y) individuals completed 2 weeks of at-home sleep monitoring using the device. Participants were between age 8-15 years, living with a caregiver, sleeping alone, and >80lbs. Caregivers completed an acceptability questionnaire at the end of the study. Sleep metrics were analyzed using repeated-measures ANOVA with fixed effects of group (ASD vs TD), day, and their interaction. Pairwise comparisons of standard deviations determined differences in night-to-night variability between groups. Results The ASD group exhibited more deep sleep (F=21.52, p< 0.001), longer sleep onset latency (F=5.13, p=0.025), and increased total wake time (F=4.56, p=0.034), whereas the TD group had more light sleep (F=5.58, p=0.019), and total interruptions (F=12.79, p< 0.001). Pairwise comparisons determined that the ASD group had greater night-to-night variability in REM sleep (t=-2.7, p=0.021). Caregivers reported the device to be highly acceptable (M=6.44; SD=1), reasonable to use (M=6.31; SD=1) and causing little to no discomfort (M=1.7; SD=1.2) on a 1-7 Likert scale. Conclusion Our results agree with previous PSG studies showing an increase in sleep onset latency and an increase in deep sleep in autistic individuals. These results provide preliminary evidence that a non-contact biomotion sensor can accurately measure and differentiate sleep between ASD and NT individuals in a naturalistic and sensory friendly manner with high levels of acceptability and low participant burden. Non-contact sensors show great promise for long-term longitudinal characterization of sleep in the home to evaluate outcomes of sleep focused interventions. Support (if any)

Year:

2025

Introduction Sleep problems are frequent in Angelman’s syndrome (AS), a neurodevelopmental disorder caused by maternal deletion of the Ube3a gene (Ube3a m-/p+). AS is characterized by a high prevalence of autism and intellectual disability. While sleep issues significantly impact individuals and caregivers, their precise nature varies across clinical studies, which are predominantly based on non-objective measures using questionnaires in children and adolescents. Studies using the Ube3a m-/p+ mouse model use objective measures but are so far limited to adult animals and show variable agreement beyond a reduction in REM sleep. The goal of this study was to examine the effects of Ube3a maternal deletion on sleep architecture and homeostasis in juvenile mice. Methods Juvenile male and female Ube3a m-/p+ mice (n= 12) and wildtype littermates (n=11-12) were implanted with EEG/EMG electrodes at postnatal day 18 (P18). Mice underwent 24-hour baseline recording, 3-hour sleep deprivation (SD) via gentle handling, and 19-hour recovery sleep at P23/P24 and P29/P30. Vigilance states (REM and NREM sleep, wake) were assigned using SPINDLE and manually corrected with SleepSign. Statistical analysis was performed using ANOVAs with age and genotype as main effects, with Benjamini-Hochberg corrected post-hoc t-tests using MATLAB. Results Our data shows that Ube3a m-/p+ mice exhibit baseline REM sleep reduction from P23 to P29, driven by decreased REM bout duration, alongside increased NREM sleep, with a significant genotype-age interaction. Despite similar sleep pressure accumulation, Ube3a mutants showed reduced sleep latency after SD, with genotype differences more pronounced in REM and NREM sleep post-SD compared to baseline levels. Conclusion Our findings support Ube3a’s role in sleep regulation, showing REM reduction and NREM increase. Thus, the mutation may impact REM sleep function earlier in life when REM quantities are greater. While sleep pressure accumulation remained unchanged, juvenile Ube3a mutant animals demonstrated reduced onset sleep latency post-SD. The sleep pressure and sleep onset results suggest that maternal Ube3a deletion induces abnormal REM/NREM sleep patterns in young ages. Support (if any) National Institute of Neurological Disorders and Stroke (NINDS) under project number 1F99NS135815 to E.M, R56NS124805 to L.P and Simons Foundation Autism Research Initiative (Pilot Award 878115) to L.P.

Year:

2025

Rett syndrome (RTT) is a severe, progressive neurodevelopmental disorder caused by mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MECP2). Sleep problems are frequently reported in Rett Syndrome, but the exact nature remains relatively unexplored. Currently there is limited understanding the role of MECP2 in sleep architecture and regulation. In this study, we employed longitudinal electroencephalographic (EEG) and electromyographic (EMG) recordings to investigate sleep architecture during baseline conditions as well as the homeostatic response to sleep deprivation (SD) in Mecp2-/y male mice. At baseline, Mecp2-/y mice have more non-rapid-eye-movement (NREM) sleep and less rapid-eye-movement (REM) sleep than their wildtype littermates during the light period. However, Mecp2-/y mice display altered sleep timing during the dark period, spending more time in both NREM and REM during the first half and less time during the second half. We also observe differences in REM sleep and wake quality based on spectral properties of the EEG. In response to SD, Mecp2-/y mice can accumulate and discharge sleep pressure normally and show a sleep rebound. However, baseline differences in sleep architecture are heightened after SD. Overall, our findings show that RTT mice exhibit distinct sleep patterns compared to wildtype mice, with time-of-day-dependent variations in NREM and REM sleep, as well as altered EEG spectral properties, that become more pronounced following SD. Future research should explore the molecular mechanisms through which MECP2 regulates circadian sleep architecture to develop targeted therapeutics for sleep disturbances in RTT patients. Highlights Mecp2 −/y mice show time-of-day-dependent alterations in NREM and REM sleep. EEG analysis revealed distinct sleep and wake quality in Mecp2 −/y mice. Sleep deprivation exacerbates baseline sleep architecture differences. Longitudinal EEG/EMG recordings captured comprehensive sleep patterns.

Year:

2025

Sleep is an essential, tightly regulated biological function. Sleep is also a homeostatic process, with the need to sleep increasing as a function of being awake. Acute sleep deprivation (SD) increases sleep need, and subsequent recovery sleep (RS) discharges it. SD is known to alter brain gene expression in rodents, but it remains unclear which changes are linked to sleep homeostasis, SD-related impairments, or non-sleep-specific effects. To investigate this question, we analyzed RNA-seq data from adult wild-type male mice subjected to 3 and 5-6 hours of SD and 2 and 6 hours of RS after SD. We hypothesized molecular changes associated with sleep homeostasis mirror sleep pressure dynamics as defined by brain electrical activity, peaking at 5-6 hours of SD, and are no longer differentially expressed after 2 hours of RS. We report 5-6 hours of SD produces the largest effect on gene expression, affecting approximately half of the cortical transcriptome, with most differentially expressed genes (DEGs) downregulated. The majority of DEGs normalize after 2 hours of RS and are involved in redox metabolism, chromatin regulation, and DNA damage/repair. Additionally, RS affects gene expression related to mitochondrial metabolism and Wnt-signaling, potentially contributing to its restorative effects. DEGs associated with cholesterol metabolism and stress response do not normalize within 6 hours and may be non-sleep-specific. Finally, DEGs involved in insulin signaling, MAPK signaling, and RNA-binding may mediate the impairing effects of SD. Overall, our results offer insight into the molecular mechanisms underlying sleep homeostasis and the broader effects of SD. New & Noteworthy This study investigates different time points of sleep deprivation and recovery sleep to better understand the molecular processes influenced by sleep and lack of sleep. This study highlights redox metabolism, chromatin regulation, and DNA damage/repair as molecular mechanisms linked to sleep homeostasis while showing the effects of stress are probably non-sleep-specific based on transcriptional dynamics.

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Collaborators (4)

Michael Rempe

Assistant Professor

Washington State University - Spokane

UNITED STATES
View details

Stephanie Hicks

Associate Professor

Johns Hopkins University Bloomberg School of Public Health

UNITED STATES
View details

Michelle Bridi

Assistant Professor

West Virginia University

UNITED STATES
View details

Ashley Ingiosi

Assistant Professor

Ohio State University

UNITED STATES
View details